Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Med Mycol ; 57(1): 101-113, 2019 Jan 01.
Article in English | MEDLINE | ID: mdl-29294039

ABSTRACT

Candida albicans is an important source of device-associated infection because of its capacity for biofilm formation. This yeast has the ability to form biofilms which favors the persistence of the infection. Furthermore, the innate immune response has a critical role in the control of these infections and macrophages (Mø) are vital to this process. An important fungicidal mechanism employed by Mø involves the generation of toxic reactive oxygen species (ROS) and reactive nitrogen intermediates (RNI). The interaction between biofilms and these immune cells, and the contribution of oxidative and nitrosative stress, that is determinant to the course of the infection, remains elusive. The aim of this study was to investigate this interaction. To this purpose, two models of Mø-biofilms contact, early (model 1) and mature (model 2) biofilms, were used; and the production of ROS, RNI and the oxidative stress response (OSR) were evaluated. We found that the presence of Mø decreased the biofilm formation at an early stage and increased the production of ROS and RNI, with activation of ORS (enzymatic and nonenzymatic). On the other hand, the interaction between mature biofilms and Mø resulted in an increasing biofilm formation, with low levels of RNI and ROS production and decrease of OSR. Dynamic interactions between Mø and fungal biofilms were also clearly evident from images obtained by confocal scanning laser microscopy. The prooxidant-antioxidant balance was different depending of C. albicans biofilms stages and likely acts as a signal over their formation in presence of Mø. These results may contribute to a better understanding of the immune-pathogenesis of C. albicans biofilm infections.


Subject(s)
Biofilms/growth & development , Candida albicans/physiology , Macrophages/microbiology , Oxidative Stress/physiology , Animals , Antifungal Agents/pharmacology , Antioxidants/metabolism , Biofilms/drug effects , Candida albicans/drug effects , Candida albicans/genetics , Drug Resistance, Fungal/genetics , Host-Pathogen Interactions , Macrophages/physiology , Mice , Models, Biological , Mutation , Nitrosative Stress/physiology , RAW 264.7 Cells , Reactive Nitrogen Species/metabolism , Reactive Oxygen Species/metabolism
2.
Toxicol In Vitro ; 29(7): 1692-700, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26130220

ABSTRACT

Shiga toxin-producing Escherichia coli (STEC) are important food-borne pathogens, with the main virulence factor of this bacterium being its capacity to secrete Shiga toxins (Stxs). Therefore, the use of certain antibiotics for the treatment of this infection, which induces the liberation of Stxs, is controversial. Reactive oxygen and nitrogen species are also involved in the pathogenesis of different diseases. The purpose of this study was to analyze the effects of antibiotics on biofilms of STEC and the relationships between cellular stress and the release of Stx. To this end, biofilms of reference and clinical strains were treated with antibiotics (ciprofloxacin, fosfomycin and rifaximin) and the production of oxidants, the antioxidant defense system and toxin release were evaluated. Ciprofloxacin altered the prooxidant-antioxidant balance, with a decrease of oxidant metabolites and an increase of superoxide dismutase and catalase activity, being associated with high-levels of Stx production. Furthermore, inhibition of oxidative stress by exogenous antioxidants was correlated with a reduction in the liberation of Stx, indicating the participation of this phenomenon in the release of this toxin. In contrast, fosfomycin and rifaximin produced less alteration with a minimal production of Stx. Our data show that treatment of biofilm-STEC with these antibiotics induces oxidative stress-mediated release of Stx.


Subject(s)
Anti-Bacterial Agents/pharmacology , Shiga Toxin 1/metabolism , Shiga Toxin 2/metabolism , Shiga-Toxigenic Escherichia coli/drug effects , Animals , Antioxidants/pharmacology , Ascorbic Acid/pharmacology , Biofilms , Catalase/metabolism , Cell Survival/drug effects , Chlorocebus aethiops , Ciprofloxacin/pharmacology , Fosfomycin/pharmacology , Glutathione/pharmacology , Microbial Sensitivity Tests , Nitric Oxide/metabolism , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism , Rifamycins/pharmacology , Rifaximin , Shiga-Toxigenic Escherichia coli/genetics , Shiga-Toxigenic Escherichia coli/metabolism , Shiga-Toxigenic Escherichia coli/physiology , Superoxide Dismutase/metabolism , Vero Cells , Virulence Factors/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...